Tenax Therapeutics (TENX) Institutional Ownership $5.85 -0.10 (-1.68%) Closing price 04:00 PM EasternExtended Trading$5.88 +0.03 (+0.43%) As of 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tenax Therapeutics (NASDAQ:TENX)CurrentInstitutional OwnershipPercentage1.67%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$2.10MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$345.86K Get TENX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tenax Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TENX Institutional Buying and Selling by Quarter Tenax Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025ADAR1 Capital Management LLC68,741$450K0.1%+98.1%1.657% 2/17/2025Vestal Point Capital LP55,189$342K0.0%-33.8%1.618% 2/17/2025Two Sigma Investments LP13,521$84K0.0%N/A0.397% 2/17/2025Millennium Management LLC26,809$166K0.0%N/A0.786% 2/17/2025Janus Henderson Group PLC166,666$1.03M0.0%N/A4.888% 2/13/2025ADAR1 Capital Management LLC34,693$215K0.0%-44.4%1.017% 2/12/2025Geode Capital Management LLC24,354$151K0.0%+32.4%0.714% 11/15/2024Sphera Funds Management LTD.29,166$101K0.0%N/A0.855% 11/14/2024Vestal Point Capital LP83,333$288K0.0%N/A2.444% 11/14/2024Stonepine Capital Management LLC50,000$173K0.1%N/A1.466% 5/1/2023Virtu Financial LLC84,361$39K0.0%N/A0.377% 11/14/2022Armistice Capital LLC1,965,885$334K0.0%+23.1%7.799% 11/5/2021PNC Financial Services Group Inc.70,000$124K0.0%N/A0.278% 10/13/2021Gofen & Glossberg LLC IL3,819,170$6.76M0.2%N/A15.155% 8/16/2021State Street Corp136,404$296K0.0%N/A0.911% 8/13/2021Renaissance Technologies LLC192,232$400K0.0%-74.3%1.284% 8/13/2021Northern Trust Corp34,671$72K0.0%+103.7%0.232% 8/13/2021Vanguard Group Inc.356,347$742K0.0%+100.3%2.381% 8/12/2021Dimensional Fund Advisors LP51,895$113K0.0%-14.1%0.347% 5/21/2021Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/18/2021Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/14/2021Dimensional Fund Advisors LP60,412$115K0.0%N/A0.404% 5/13/2021Renaissance Technologies LLC747,832$1.42M0.0%+75.1%4.996% 5/12/2021Geode Capital Management LLC52,301$99K0.0%+58.5%0.349% (Data available from 1/1/2016 forward) TENX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TENX shares? During the previous two years, the following institutional investors and hedge funds held shares of Tenax Therapeutics shares: Janus Henderson Group PLC ($1.03M), ADAR1 Capital Management LLC ($450K), Vestal Point Capital LP ($342K), Stonepine Capital Management LLC ($173K), Millennium Management LLC ($166K), Geode Capital Management LLC ($151K), and Sphera Funds Management LTD. ($101K).Learn more on Tenax Therapeutics' institutional investors. What percentage of Tenax Therapeutics' stock is owned by institutional investors? 1.67% of Tenax Therapeutics' stock is owned by institutional investors. Learn more on TENX's institutional investor holdings. Which institutional investors have been buying Tenax Therapeutics' stock? The following institutional investors have purchased Tenax Therapeutics' stock in the last 24 months: Janus Henderson Group PLC ($166.67K), Vestal Point Capital LP ($83.33K), Stonepine Capital Management LLC ($50K), ADAR1 Capital Management LLC ($34.05K), Sphera Funds Management LTD. ($29.17K), Millennium Management LLC ($26.81K), and Two Sigma Investments LP ($13.52K). How much institutional buying is happening at Tenax Therapeutics? Institutional investors have bought a total of 409,507 shares in the last 24 months. This purchase volume represents approximately $2.10M in transactions. Which of Tenax Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Tenax Therapeutics stock in the last 24 months: Vestal Point Capital LP ($28.14K), and ADAR1 Capital Management LLC ($27.73K). How much institutional selling is happening at Tenax Therapeutics? Institutional investors have sold a total of 55,874 shares in the last 24 months. This volume of shares sold represents approximately $345.86K in transactions. Related Companies Corbus Pharmaceuticals Major Shareholders OKYO Pharma Major Shareholders Coherus Oncology Major Shareholders MacroGenics Major Shareholders OncoCyte Major Shareholders Zentalis Pharmaceuticals Major Shareholders Forte Biosciences Major Shareholders BeyondSpring Major Shareholders Oramed Pharmaceuticals Major Shareholders Invivyd Major Shareholders This page (NASDAQ:TENX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENX Stock Alerts